Florida Health Daily
SEE OTHER BRANDS

Your best source on healthcare and wellness news from Florida

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on May 23, 2025

Ideal Physical Therapy and Fitness Integrates Spinal Decompression and Physical Therapy for Holistic Pain Relief

Ideal Physical Therapy and Fitness Integrates Spinal Decompression and Physical Therapy for Holistic Pain Relief

Ideal Physical Therapy and Fitness delivers non-invasive relief in Naples by uniting spinal decompression, physical therapy, and fitness under one roof. NAPLES, FL, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- Ideal Physical Therapy and Fitness has …

ACCESS Specialty Animal Hospital Expands Outreach with First-of-Its-Kind K9 Emergency Training for First Responders

ACCESS Specialty Animal Hospital Expands Outreach with First-of-Its-Kind K9 Emergency Training for First Responders

ACCESS Specialty Animal Hospital Trains First Responders with Hands-On K9 Emergency Training at Palm Beach State College Invitational. ROYAL PALM BEACH, FL, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- ACCESS Specialty Animal Hospital – Palm Beach …

Orlando Dentist Dr. Cuong T. Phan Now VA-Certified to Provide Dental Care to Eligible Veterans

Orlando Dentist Dr. Cuong T. Phan Now VA-Certified to Provide Dental Care to Eligible Veterans

ORLANDO, FL, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- Veterans in Central Florida now have expanded access to dental care as Dr. Cuong T. Phan of Phan-tastic Smiles has officially received certification from the U.S. Department of Veterans …

Armanite Launches WarehouseStop.com, Expanding Its Housewares Legacy and Embracing the Growing Chemical Industry

Armanite Launches WarehouseStop.com, Expanding Its Housewares Legacy and Embracing the Growing Chemical Industry

WEST PALM BEACH, FL, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- Armanite, a Florida-based company with a proven track record as a power seller in the housewares category on Amazon, proudly announces the launch of its new e-commerce platform: …

BioSig Technologies, Inc. Signs Definitive Share Exchange Agreement with Streamex Exchange Corp. to Launch First-Mover Real-World Asset (RWA) Tokenization Company Bringing Commodity Markets On-Chain.

BioSig Technologies, Inc. Signs Definitive Share Exchange Agreement with Streamex Exchange Corp. to Launch First-Mover Real-World Asset (RWA) Tokenization Company Bringing Commodity Markets On-Chain.

Los Angeles, CA and Vancouver, BC, May 23, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company, today announced it has signed a definitive share exchange agreement with Streamex …

IMUNON Announces Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules

IMUNON Announces Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules

$3.25 million upfront with up to an additional $6.5 million of potential aggregate gross proceeds  upon the exercise in full of short-term warrants LAWRENCEVILLE, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company …

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, May 23, 2025 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”) announced today that its shareholders voted in …

Information on the total number of voting rights and shares

Information on the total number of voting rights and shares

Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), May 23, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article  15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext …

Informations sur le nombre total de droits de vote et d'actions

Informations sur le nombre total de droits de vote et d'actions

Informations sur le nombre total de droits de vote et d'actions Mont-Saint-Guibert (Belgique), le 23 mai 2025, 22:30h CET / 16:30h ET – Conformément à l'article 15 de la loi du 2 mai 2007 relative à la publicité des participations importantes, Nyxoah SA ( …

Polyrizon Announces Receipt of Nasdaq Delisting Notice

Polyrizon Announces Receipt of Nasdaq Delisting Notice

Raanana, Israel, May 23, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced that it has received a …

Plus Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

Plus Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

HOUSTON, May 23, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) today announced it received a delinquency notification letter from Nasdaq on May 21, 2025, which indicated that the Company was not in compliance with Nasdaq …

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

IRVINE, Calif., May 23, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications, …

PMV Pharmaceuticals to Participate at Upcoming Investor Conferences

PMV Pharmaceuticals to Participate at Upcoming Investor Conferences

PRINCETON, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that …

Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F

Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F

Jilin, China, May 23, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, …

Boundless Bio Announces Portfolio Prioritization and Runway Extension

Boundless Bio Announces Portfolio Prioritization and Runway Extension

Portfolio prioritization focuses on novel-novel combination therapy of BBI-355 and BBI-825 and new development candidate, BBI-940, for novel kinesin program Operating runway extended into the first half of 2028, through expected proof-of-concept clinical …

Tevogen Bio Plans to Expand Specialty Care Pipeline to Include Patients 65+, Building on Previous Forecast of Nearly $1 Billion in Launch-Year; Updated rNPV to Follow

Tevogen Bio Plans to Expand Specialty Care Pipeline to Include Patients 65+, Building on Previous Forecast of Nearly $1 Billion in Launch-Year; Updated rNPV to Follow

WARREN, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced a planned expansion of TVGN 489’s target population to include patients 65 and older. As previously reported in October 2024, …

Cross Medical Group Introduces HydraFacial Treatments for Advanced Skin Rejuvenation

Cross Medical Group Introduces HydraFacial Treatments for Advanced Skin Rejuvenation

PHILADELPHIA and VILLANOVA, Pa., May 23, 2025 (GLOBE NEWSWIRE) -- Cross Medical Group is pleased to announce that HydraFacial treatments are now available at the practice. A HydraFacial at their Philadelphia and Villanova offices, which is sometimes …

U.S. FDA Approves Liquidia’s YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

U.S. FDA Approves Liquidia’s YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

FDA’s approval of YUTREPIA paves the way for prescribers to add a new treatment option for patients with PAH and PH-ILD YUTREPIA is designed to enhance deep-lung delivery with an easy-to-use device requiring low inspiratory effort Demonstrated tolerability …

MediPharm Labs Cautions Shareholders about Dissident Nominees’ Governance Failures at Check-Cap Ltd.

MediPharm Labs Cautions Shareholders about Dissident Nominees’ Governance Failures at Check-Cap Ltd.

TORONTO, May 23, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (“MediPharm”, the “Company”, or “we”), a pharmaceutical company specialized in precision-based cannabinoids, today provided its shareholders with information related to three of the …

Mind Body Peak Performance Rebrands to ‘High Performance Longevity’ Podcast, Integrating Biohacking with Ancestral Wisdom

Mind Body Peak Performance Rebrands to ‘High Performance Longevity’ Podcast, Integrating Biohacking with Ancestral Wisdom

Austin, TX, May 23, 2025 (GLOBE NEWSWIRE) -- Outliyr, a performance health brand known for combining modern biohacking with ancestral wisdom, has rebranded its podcast—formerly Mind Body Peak Performance—as High Performance Longevity to reflect a deeper …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service